Avinger Inc (AVGR) - Net Assets

Latest as of September 2024: $3.88 Million USD

Based on the latest financial reports, Avinger Inc (AVGR) has net assets worth $3.88 Million USD as of September 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.60 Million) and total liabilities ($9.73 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AVGR cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $3.88 Million
% of Total Assets 28.49%
Annual Growth Rate N/A
5-Year Change -189.95%
10-Year Change N/A
Growth Volatility 323.19

Avinger Inc - Net Assets Trend (2012–2023)

This chart illustrates how Avinger Inc's net assets have evolved over time, based on quarterly financial data. Also explore AVGR total asset value for the complete picture of this company's asset base.

Annual Net Assets for Avinger Inc (2012–2023)

The table below shows the annual net assets of Avinger Inc from 2012 to 2023. For live valuation and market cap data, see Avinger Inc stock valuation.

Year Net Assets Change
2023-12-31 $-6.20 Million -249.59%
2022-12-31 $4.15 Million -57.36%
2021-12-31 $9.72 Million -25.64%
2020-12-31 $13.08 Million +89.64%
2019-12-31 $6.89 Million -27.11%
2018-12-31 $9.46 Million +126.51%
2017-12-31 $-35.69 Million -941.55%
2016-12-31 $4.24 Million -72.79%
2015-12-31 $15.59 Million +110.84%
2014-12-31 $-143.87 Million -27.56%
2013-12-31 $-112.78 Million -53.14%
2012-12-31 $-73.64 Million --

Equity Component Analysis

This analysis shows how different components contribute to Avinger Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 34602800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Common Stock $1.00K %
Other Components $414.49 Million %
Total Equity $-6.20 Million 100.00%

Avinger Inc Competitors by Market Cap

The table below lists competitors of Avinger Inc ranked by their market capitalization.

Company Market Cap
Aptitude Software Group PLC
LSE:APTD
$1.52 Million
CBEYOND
F:C5B
$1.52 Million
Ngenic AB
ST:NGENIC
$1.53 Million
DELPHI WORLD MONEY LIMITED
NSE:DELPHIFX
$1.53 Million
Ausmon Resources Ltd
AU:AOA
$1.51 Million
TrustBIX Inc
V:TBIX
$1.51 Million
Yida China Holdings Ltd
STU:YC2
$1.51 Million
CONSOLE LABS SA ZY-10
F:9ZK
$1.51 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Avinger Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 4,146,000 to -6,202,000, a change of -10,348,000 (-249.6%).
  • Net loss of 18,320,000 reduced equity.
  • New share issuances of 5,112,000 increased equity.
  • Other factors increased equity by 2,860,000.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income $-18.32 Million -295.39%
Share Issuances $5.11 Million +82.43%
Other Changes $2.86 Million +46.11%
Total Change $- -249.59%

Book Value vs Market Value Analysis

This analysis compares Avinger Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 $-898097.56 $0.47 x
2013-12-31 $-1375390.24 $0.47 x
2014-12-31 $-1754487.80 $0.47 x
2015-12-31 $148466.67 $0.47 x
2016-12-31 $21419.19 $0.47 x
2017-12-31 $-128844.77 $0.47 x
2018-12-31 $2655.81 $0.47 x
2019-12-31 $285.76 $0.47 x
2020-12-31 $79.68 $0.47 x
2021-12-31 $30.89 $0.47 x
2022-12-31 $9.95 $0.47 x
2023-12-31 $-7.89 $0.47 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Avinger Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -239.41%
  • • Asset Turnover: 0.56x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-249.16%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 0.00% -395.61% 0.28x 0.00x $-26.50 Million
2013 0.00% -307.78% 0.52x 0.00x $-28.62 Million
2014 0.00% -285.06% 0.45x 0.00x $-17.58 Million
2015 -303.70% -441.93% 0.20x 3.47x $-48.90 Million
2016 -1323.46% -292.12% 0.36x 12.63x $-56.55 Million
2017 0.00% -490.56% 0.66x 0.00x $-45.16 Million
2018 -291.31% -348.17% 0.33x 2.51x $-28.50 Million
2019 -286.47% -216.32% 0.38x 3.46x $-20.44 Million
2020 -151.60% -226.26% 0.26x 2.54x $-21.13 Million
2021 -213.00% -204.44% 0.34x 3.03x $-21.68 Million
2022 -420.33% -210.65% 0.34x 5.84x $-17.84 Million
2023 0.00% -239.41% 0.56x 0.00x $-17.70 Million

Industry Comparison

This section compares Avinger Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,078,746,985
  • Average return on equity (ROE) among peers: -19.73%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Avinger Inc (AVGR) $3.88 Million 0.00% 2.51x $1.52 Million
Akoya Biosciences Inc (AKYA) $121.35 Million -35.38% 0.57x $64.44 Million
Align Technology Inc (ALGN) $1.35 Billion 32.89% 0.86x $12.66 Billion
AngioDynamics Inc (ANGO) $517.03 Million -1.36% 0.37x $444.32 Million
AptarGroup Inc (ATR) $2.71 Billion 14.48% 0.94x $7.66 Billion
AtriCure Inc (ATRC) $16.74 Million -22.66% 1.01x $1.44 Billion
Anteris Technologies Global Corp. Common Stock (AVR) $10.52 Million -163.15% 1.04x $156.14 Million
Avantor Inc (AVTR) $5.57 Billion -9.53% 1.12x $5.43 Billion
Azenta Inc (AZTA) $553.69 Million -12.55% 0.24x $1.04 Billion
Baxter International Inc (BAX) $7.87 Billion 19.65% 1.00x $8.85 Billion

About Avinger Inc

NASDAQ:AVGR USA Medical Instruments & Supplies
Market Cap
$1.52 Million
Market Cap Rank
#29922 Global
#5836 in USA
Share Price
$0.47
Change (1 day)
+0.00%
52-Week Range
$0.47 - $0.47
All Time High
$1000000.00
About

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to prov… Read more